The Middle East & Africa Pain Management Devices Market Size is valued at USD 0.47 billion in 2022 and is expected to grow at a CAGR of 8.5% to reach USD 0.70 billion by 2027 during the forecast period.
Pain is caused due to the unpleasant sensory stimulation caused due to damage to the tissues by any means. It is majorly caused by injuries and in the case of diseases such as arthritis, ulcers, cancer, and multiple sclerosis. Acute pain is generated for a short period, whereas chronic pain is persistent for extended time periods.
Several drugs and devices are available in the market to assist in pain management. These devices work by blocking the nerve stimulators by transmitting the unpleasant sensory experience to the brain. Neurostimulation devices, ablation devices, and analgesic infusion pumps are some of the pain management devices. Neurostimulators block pain by supplying specific frequencies of current to prevent the passage of signals.
An increase in demand for alternatives for pain management drugs, which cause many side effects, a large number of patients with chronic diseases, especially in the geriatric population, and technological advancements to develop better pain management devices are expected to drive the market. In addition, an increase in cancer patients and an increase in neuropathic diseases are also boosting the pain management devices market. However, side effects associated with using these devices, such as hypersensitivity and redness of the skin and high manufacturing costs, are restraining the market.
This research report on the MEA pain management devices market has been segmented and sub-segmented into the following categories:
By Device Type:
By Mode of Purchase:
Based on the region, the Middle East region has the largest market share due to the increasing awareness among people regarding the people and increasing chronic diseases in this region. On the other hand, the market growth is somewhat slow in the Africa region due to people's low per capita income.
KEY MARKET PLAYERS:
Some of the prominent companies in the MEA pain management devices market profiled in the report are St. Jude Medical, Inc., Boston Scientific Corporation, Medtronic plc, Baxter International, Stryker Corporation, Pfizer, Codman and Shurtleff, B Braun Melsungen AG, and DJO Global LLC.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com